PURPOSE: This paper presents methods and operational results of a population-based case-control study examining the effects of oral contraceptive use on breast cancer risk among white and black women aged 35-64 years in five U.S. locations. METHODS: Cases were women newly diagnosed with breast cancer during July 1994 through April 1998. Controls were identified through random digit dialing (RDD) using unclustered sampling with automated elimination of nonworking numbers. Sampling was density-based, with oversampling of black women. In-person interviews were conducted from August 1994 through December 1998. Blood samples were obtained from subsets of cases and controls, and tissue samples were obtained from subsets of cases. A computerized system tracked subjects through study activities. Special attention was devoted to minimizing exposure misclassification, because any exposure-disease associations were expected to be small. RESULTS: An estimated 82% of households were screened successfully through RDD. Interviews were completed for 4575 cases (2953 whites; 1622 blacks) and 4682 controls (3021 whites; 1661 blacks). Interview response rates for cases and controls were 76.5% and 78.6%, respectively, with lower rates for black women and older women. CONCLUSIONS: The methodologic details of this large collaboration may assist researchers conducting similar investigations.
PURPOSE: This paper presents methods and operational results of a population-based case-control study examining the effects of oral contraceptive use on breast cancer risk among white and black women aged 35-64 years in five U.S. locations. METHODS: Cases were women newly diagnosed with breast cancer during July 1994 through April 1998. Controls were identified through random digit dialing (RDD) using unclustered sampling with automated elimination of nonworking numbers. Sampling was density-based, with oversampling of black women. In-person interviews were conducted from August 1994 through December 1998. Blood samples were obtained from subsets of cases and controls, and tissue samples were obtained from subsets of cases. A computerized system tracked subjects through study activities. Special attention was devoted to minimizing exposure misclassification, because any exposure-disease associations were expected to be small. RESULTS: An estimated 82% of households were screened successfully through RDD. Interviews were completed for 4575 cases (2953 whites; 1622 blacks) and 4682 controls (3021 whites; 1661 blacks). Interview response rates for cases and controls were 76.5% and 78.6%, respectively, with lower rates for black women and older women. CONCLUSIONS: The methodologic details of this large collaboration may assist researchers conducting similar investigations.
Authors: Kerryn W Reding; Christopher S Carlson; Orsalem Kahsai; Christina C Chen; Andrew McDavid; David R Doody; Chu Chen; India Ornelas; Kimberly Lowe; Leslie Bernstein; Linda Weiss; Jill A McDonald; Michael S Simon; Brian Strom; Polly A Marchbanks; Ronald Burkman; Robert Spirtas; Jonathan M Liff; Kathleen E Malone Journal: Breast Cancer Res Treat Date: 2012-05-31 Impact factor: 4.872
Authors: Paula Berstad; Ralph J Coates; Leslie Bernstein; Suzanne G Folger; Kathleen E Malone; Polly A Marchbanks; Linda K Weiss; Jonathan M Liff; Jill A McDonald; Brian L Strom; Michael S Simon; Dennis Deapen; Michael F Press; Ronald T Burkman; Robert Spirtas; Giske Ursin Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05-25 Impact factor: 4.254
Authors: Polly A Marchbanks; Kathryn M Curtis; Michele G Mandel; Hoyt G Wilson; Gary Jeng; Suzanne G Folger; Jill A McDonald; Janet R Daling; Leslie Bernstein; Kathleen E Malone; Phyllis A Wingo; Michael S Simon; Sandra A Norman; Brian L Strom; Giske Ursin; Linda K Weiss; Ronald T Burkman; Robert Spirtas Journal: Contraception Date: 2011-09-28 Impact factor: 3.375
Authors: Sandra A Norman; Anita L Weber; A Russell Localio; Polly A Marchbanks; Giske Ursin; Brian L Strom; Linda K Weiss; Ronald T Burkman; Leslie Bernstein; Dennis M Deapen; Suzanne G Folger; Michael S Simon; Marion R Nadel Journal: Pharmacoepidemiol Drug Saf Date: 2010-05 Impact factor: 2.890
Authors: Kerryn W Reding; David R Doody; Anne McTiernan; Li Hsu; Scott Davis; Janet R Daling; Peggy L Porter; Kathleen E Malone Journal: Breast Cancer Res Treat Date: 2010-09-29 Impact factor: 4.872
Authors: Jennifer A Doherty; Noel S Weiss; Sherianne Fish; Wenhong Fan; Melissa M Loomis; Lori C Sakoda; Mary Anne Rossing; Lue Ping Zhao; Chu Chen Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-07-12 Impact factor: 4.254
Authors: Christopher I Li; Kathleen E Malone; Janet R Daling; John D Potter; Leslie Bernstein; Polly A Marchbanks; Brian L Strom; Michael S Simon; Michael F Press; Giske Ursin; Ronald T Burkman; Suzanne G Folger; Sandra Norman; Jill A McDonald; Robert Spirtas Journal: Am J Epidemiol Date: 2007-10-26 Impact factor: 4.897
Authors: Veronica Wendy Setiawan; Li-Hao Chu; Esther M John; Yuan Chun Ding; Sue A Ingles; Leslie Bernstein; Michael F Press; Giske Ursin; Christopher A Haiman; Susan L Neuhausen Journal: Cancer Genet Cytogenet Date: 2008-02
Authors: Page E Abrahamson; Shelley S Tworoger; Erin J Aiello; Leslie Bernstein; Cornelia M Ulrich; Frank D Gilliland; Frank Z Stanczyk; Richard Baumgartner; Kathy Baumgartner; Bess Sorensen; Rachel Ballard-Barbash; Anne McTiernan Journal: Breast Cancer Res Treat Date: 2006-11-01 Impact factor: 4.872
Authors: Laura P Forsythe; Catherine M Alfano; Stephanie M George; Anne McTiernan; Kathy B Baumgartner; Leslie Bernstein; Rachel Ballard-Barbash Journal: Breast Cancer Res Treat Date: 2012-12-15 Impact factor: 4.872